Search Result "Remsima"


Review Article

The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 44 Year: 2017 Page: 6759-6769
Author(s): Pedro Avila-Ribeiro,Gionata Fiorino,Silvio Danese

Review Article

Efficacy, Safety and Immunogenicity of Biosimilars in Inflammatory Bowel Diseases: A Systematic Review

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 2 Year: 2019 Page: 270-279
Author(s): Laura Martelli,Laurent Peyrin-Biroulet

Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs (Discontinued)
Volume: 2 Issue: 3 Year: 2015 Page: 158-164
Author(s): Ajmer S. Grewal,Viney Lather,Shashikant Bhardwaj,Deepti Pandita

Review Article

Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment

Journal: Current Drug Targets
Volume: 19 Issue: 7 Year: 2018 Page: 757-776
Author(s): Erwin Dreesen,Ann Gils,Severine Vermeire

Review Article

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 2 Year: 2019 Page: 280-287
Author(s): Silvio Danese,Gionata Fiorino

Review Article

Insight of Engineered Nano-based Biologics Approaches used to CombatAutoimmune Disease using TNF-α & IL Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 19 Year: 2023 Page: 1793-1806
Author(s):

Review Article

The Experience with Biosimilars of Infliximab in Rheumatic Diseases

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 44 Year: 2017 Page: 6752-6758
Author(s): Valderilio Feijo Azevedo,Igor Age Kos,Leonardo Ariello

Review Article

Can We Extrapolate Data from One Immune-Mediated Inflammatory Disease to Another One?

Journal: Current Medicinal Chemistry
Volume: 26 Issue: 2 Year: 2019 Page: 248-258
Author(s): Fernando Magro,Rosa Coelho,Armando Peixoto

Review Article

Biosimilars in IBD: Will it Benefit to Patients, Physicians or the Health Care System?

Journal: Current Pharmaceutical Design
Volume: 25 Issue: 1 Year: 2019 Page: 13-18
Author(s): Lorant Gonczi,Akos Ilias,Zsuzsanna Kurti,Peter L. Lakatos

open access plus

Effect of Thermal and Shear Stressors on the Physical Properties, Structural Integrity and Biological Activity of the Anti-TNF-alpha Monoclonal Antibody, Infliximab

Journal: Current Pharmaceutical Biotechnology
Volume: 17 Issue: 10 Year: 2016 Page: 905-914
Author(s): Jihad A. Alsaddique,Ritesh M. Pabari,Zebunnissa Ramtoola

Previous   Next

Go To   Results 1 - 1 of 12

Apply Filters

Volume Years
Article Type
    Publication Title
    Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy